These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24729605)

  • 1. Novel oral anti-influenza drug candidate AV5080.
    Ivachtchenko AV; Ivanenkov YA; Mitkin OD; Yamanushkin PM; Bichko VV; Shevkun NA; Karapetian RN; Leneva IA; Borisova OV; Veselov MS
    J Antimicrob Chemother; 2014 Jul; 69(7):1892-902. PubMed ID: 24729605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
    Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W
    J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
    Ikematsu H; Kawai N
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.
    Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C
    Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel oral anti-influenza prodrug candidate AV5075S.
    Ivachtchenko AV; Ivanenkov YA; Mitkin OD; Yamanushkin PM; Bichko VV; Shevkun NA; Mokrushina OV; Nevolina OO; Karapetian RN; Leneva IA; Fedyakina IT; Veselov MS
    J Antimicrob Chemother; 2014 May; 69(5):1311-24. PubMed ID: 24428978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a non-zwitterionic oseltamivir analogue as a potent influenza a neuraminidase inhibitor.
    Zhang H; Wang K; Zhu H; Zhao X; Zhao H; Lei Z; Chen B; Yang F; Liu K; Zhang K; Wang J; Tian Y
    Eur J Med Chem; 2020 Aug; 200():112423. PubMed ID: 32512482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo.
    Tian L; Wang Z; Wu H; Wang S; Wang Y; Wang Y; Xu J; Wang L; Qi F; Fang M; Yu D; Fang X
    J Ethnopharmacol; 2011 Sep; 137(1):534-42. PubMed ID: 21699971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A.
    Schade D; Kotthaus J; Riebling L; Kotthaus J; Müller-Fielitz H; Raasch W; Koch O; Seidel N; Schmidtke M; Clement B
    J Med Chem; 2014 Feb; 57(3):759-69. PubMed ID: 24422530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.
    Meeprasert A; Khuntawee W; Kamlungsua K; Nunthaboot N; Rungrotmongkol T; Hannongbua S
    J Mol Graph Model; 2012 Sep; 38():148-54. PubMed ID: 23079644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity.
    Shie JJ; Fang JM; Wang SY; Tsai KC; Cheng YS; Yang AS; Hsiao SC; Su CY; Wong CH
    J Am Chem Soc; 2007 Oct; 129(39):11892-3. PubMed ID: 17850083
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2014 Feb; 20(2):77-80. PubMed ID: 24560563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
    Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
    Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of C-4-modified zanamivir analogs as neuraminidase inhibitors and their anti-AIV activities.
    Ye D; Shin WJ; Li N; Tang W; Feng E; Li J; He PL; Zuo JP; Kim H; Nam KY; Zhu W; Seong BL; No KT; Jiang H; Liu H
    Eur J Med Chem; 2012 Aug; 54():764-70. PubMed ID: 22795831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach.
    Karthick V; Shanthi V; Rajasekaran R; Ramanathan K
    Appl Biochem Biotechnol; 2012 May; 167(2):237-49. PubMed ID: 22544690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of NH
    Wang K; Yang F; Wang L; Liu K; Sun L; Lin B; Hu Y; Wang B; Cheng M; Tian Y
    Eur J Med Chem; 2017 Dec; 141():648-656. PubMed ID: 29107426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virus resistance to neuraminidase inhibitors.
    Samson M; Pizzorno A; Abed Y; Boivin G
    Antiviral Res; 2013 May; 98(2):174-85. PubMed ID: 23523943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.
    Abed Y; Nehmé B; Baz M; Boivin G
    Antiviral Res; 2008 Feb; 77(2):163-6. PubMed ID: 17919743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata.
    Dao TT; Nguyen PH; Lee HS; Kim E; Park J; Lim SI; Oh WK
    Bioorg Med Chem Lett; 2011 Jan; 21(1):294-8. PubMed ID: 21123068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
    Rungrotmongkol T; Frecer V; De-Eknamkul W; Hannongbua S; Miertus S
    Antiviral Res; 2009 Apr; 82(1):51-8. PubMed ID: 19428595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1.
    Duwe S; Schweiger B
    J Virol Methods; 2008 Nov; 153(2):134-41. PubMed ID: 18725246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.